These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 18669619)

  • 41. Proteomics approaches towards antigen discovery and vaccine development.
    Klade CS
    Curr Opin Mol Ther; 2002 Jun; 4(3):216-23. PubMed ID: 12139306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel antigen design for the generation of antibodies to G-protein-coupled receptors.
    Larsson K; Hofström C; Lindskog C; Hansson M; Angelidou P; Hökfelt T; Uhlén M; Wernérus H; Gräslund T; Hober S
    J Immunol Methods; 2011 Jul; 370(1-2):14-23. PubMed ID: 21605562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RNA deep sequencing as a tool for selection of cell lines for systematic subcellular localization of all human proteins.
    Danielsson F; Wiking M; Mahdessian D; Skogs M; Ait Blal H; Hjelmare M; Stadler C; Uhlén M; Lundberg E
    J Proteome Res; 2013 Jan; 12(1):299-307. PubMed ID: 23227862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel bioinformatic identification of differentially expressed tissue-specific and cancer-related proteins from the Human Protein Atlas for biomarker discovery.
    Liu XX; Liu FJ
    Genet Mol Res; 2015 May; 14(2):4557-65. PubMed ID: 25966229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody Validation in Bioimaging Applications Based on Endogenous Expression of Tagged Proteins.
    Skogs M; Stadler C; Schutten R; Hjelmare M; Gnann C; Björk L; Poser I; Hyman A; Uhlén M; Lundberg E
    J Proteome Res; 2017 Jan; 16(1):147-155. PubMed ID: 27723985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The human protein atlas-Integrated omics for single cell mapping of the human proteome.
    Digre A; Lindskog C
    Protein Sci; 2023 Feb; 32(2):e4562. PubMed ID: 36604173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced Validation of Antibodies Enables the Discovery of Missing Proteins.
    Sivertsson Å; Lindström E; Oksvold P; Katona B; Hikmet F; Vuu J; Gustavsson J; Sjöstedt E; von Feilitzen K; Kampf C; Schwenk JM; Uhlén M; Lindskog C
    J Proteome Res; 2020 Dec; 19(12):4766-4781. PubMed ID: 33170010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systematic analysis of human kinase genes: a large number of genes and alternative splicing events result in functional and structural diversity.
    Milanesi L; Petrillo M; Sepe L; Boccia A; D'Agostino N; Passamano M; Di Nardo S; Tasco G; Casadio R; Paolella G
    BMC Bioinformatics; 2005 Dec; 6 Suppl 4(Suppl 4):S20. PubMed ID: 16351747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody-Based Proteomics.
    Wingren C
    Adv Exp Med Biol; 2016; 926():163-179. PubMed ID: 27686812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Approaches for systematic proteome exploration.
    Falk R; Ramström M; Ståhl S; Hober S
    Biomol Eng; 2007 Jun; 24(2):155-68. PubMed ID: 17376740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteins.
    Grifantini R; Pagani M; Pierleoni A; Grandi A; Parri M; Campagnoli S; Pileri P; Cattaneo D; Canidio E; Pontillo A; De Camilli E; Bresciani A; Marinoni F; Pedrazzoli E; Nogarotto R; Abrignani S; Viale G; Sarmientos P; Grandi G
    J Proteomics; 2011 Dec; 75(2):532-47. PubMed ID: 21920474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody technology in proteomics.
    Saerens D; Ghassabeh GH; Muyldermans S
    Brief Funct Genomic Proteomic; 2008 Jul; 7(4):275-82. PubMed ID: 18586755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer.
    Meehan KL; Holland JW; Dawkins HJ
    Prostate; 2002 Jan; 50(1):54-63. PubMed ID: 11757036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immuno-detection by sequencing enables large-scale high-dimensional phenotyping in cells.
    van Buggenum JAG; Gerlach JP; Tanis SEJ; Hogeweg M; Jansen PWTC; Middelwijk J; van der Steen R; Vermeulen M; Stunnenberg HG; Albers CA; Mulder KW
    Nat Commun; 2018 Jun; 9(1):2384. PubMed ID: 29921844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Towards proteome scale antibody selections using phage display.
    Mersmann M; Meier D; Mersmann J; Helmsing S; Nilsson P; Gräslund S; ; Colwill K; Hust M; Dübel S
    N Biotechnol; 2010 May; 27(2):118-28. PubMed ID: 19883803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-Density Antigen Microarrays for the Assessment of Antibody Selectivity and Off-Target Binding.
    Sjöberg R; Andersson E; Hellström C; Mattsson C; Schwenk JM; Nilsson P; Ayoglu B
    Methods Mol Biol; 2018; 1785():231-238. PubMed ID: 29714022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Human Protein Atlas - an important resource for basic and clinical research.
    Lindskog C
    Expert Rev Proteomics; 2016 Jul; 13(7):627-9. PubMed ID: 27276068
    [No Abstract]   [Full Text] [Related]  

  • 58. Rapid antibody quantification and generation of whole proteome antibody response profiles using LIPS (luciferase immunoprecipitation systems).
    Burbelo PD; Ching KH; Mattson TL; Light JS; Bishop LR; Kovacs JA
    Biochem Biophys Res Commun; 2007 Jan; 352(4):889-95. PubMed ID: 17157815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human protein atlas and the use of microarray technologies.
    Hober S; Uhlén M
    Curr Opin Biotechnol; 2008 Feb; 19(1):30-5. PubMed ID: 18187316
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.